Hasty Briefsbeta

Bilingual

Hepatocellular carcinoma: Clinical trials to watch - PubMed

5 hours ago
  • #immune checkpoint inhibitors
  • #hepatocellular carcinoma
  • #clinical trials
  • Ongoing trials for hepatocellular carcinoma (HCC) screening and treatment have transformative potential.
  • Screening trials are comparing novel imaging and blood-based strategies versus abdominal ultrasound for early HCC detection.
  • Immune checkpoint inhibitors have significantly changed HCC treatment, with trials exploring benefits in early-stage, intermediate-stage, and advanced-stage HCC.
  • New regimens are being evaluated to improve survival rates for advanced-stage HCC.